Susquehanna International Group
DOVA

Susquehanna International Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Susquehanna International Group’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-148,600
Closed -$4.15M – 11203
2019
Q3 		$4.15M Buy
148,600
+44,900
+43% +$727K ﹤0.01% 2977
2019
Q2 		$1.46M Buy
103,700
+41,200
+66% +$392K ﹤0.01% 4835
2019
Q1 		$556K Buy
+62,500
New +$507K ﹤0.01% 6058

Susquehanna International Group's DOVA Position: Q3 2019 in Review

Susquehanna International Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2019, closing a stake of 14,854 shares — an estimated $241K sold.

Susquehanna International Group first reported a position in DOVA in Q3 2018 and held it in 2 quarters. The position peaked at $993K in Q3 2018. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

  • Susquehanna International Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Susquehanna International Group sold 14,854 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $241K.
  • Susquehanna International Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
  • Susquehanna International Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $993K in Q3 2018.
  • 72 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.